/

Other

/

EMD Serono, Inc.

EMD Serono, Inc.

EMD Serono, Inc.

Verified Nov 2026

Other

·

United States flag

Rockland, Massachusetts

·

Since

EMD Serono is the U.S. and Canadian biopharmaceutical division of Merck KGaA, headquartered in Rockland, Massachusetts, with 1,000–5,000 employees and revenue between $500M–1B. The company develops therapies in neurology, endocrinology, oncology, and immunology, serving patients with multiple sclerosis, infertility, cancer, and myasthenia gravis. In 2026, the company received FDA approval for pimicotinib and acquired PostEra's fertility programs to expand its treatment portfolio.

EMD Serono, Inc.

Verified Nov 2026

AT A GLANCE

Founded

Headquarters

United States flag

Rockland, Massachusetts

Employees

1,000-5,000

Ownership

EMD Serono, Inc. at a glance

Revenue

$500M-1B

Est. band

Employees

1,000-5,000

Headquarters

Rockland, Massachusetts

Industries

Automotive

Electric Vehicles

Medical

Industrial Equipment

Overview

EMD Serono is the U.S. and Canadian biopharmaceutical division of Merck KGaA, headquartered in Rockland, Massachusetts, with 1,000–5,000 employees and revenue between $500M–1B. The company develops therapies in neurology, endocrinology, oncology, and immunology, serving patients with multiple sclerosis, infertility, cancer, and myasthenia gravis. In 2026, the company received FDA approval for pimicotinib and acquired PostEra's fertility programs to expand its treatment portfolio.

At a glance

Attribute

Detail

Headquarters

Rockland, Massachusetts

Employees

1,000-5,000

Revenue

$500M-1B (estimated)

What EMD Serono, Inc. makes

The company provides drug-delivery devices alongside eight marketed drugs in the U.S. since 2017 and offers comprehensive patient support services throughout treatment.

Products and capabilities described on the company's own site include Electronics, Steel, Lighting (source: emdserono.com).

Latest developments

Facilities

EMD Serono, Inc. is headquartered in Rockland, Massachusetts. Public sources also reference these locations:

Company details

EMD Serono operates as a subsidiary of Merck KGaA with research and manufacturing sites across multiple U.S. locations and maintains active collaborations with external research partners such as Versant Ventures. EMD Serono, Inc. has an estimated 1,000-5,000 employees, and is headquartered in Rockland, Massachusetts.

Frequently asked questions

What does EMD Serono, Inc. do?

EMD Serono is the U.S. and Canadian biopharmaceutical division of Merck KGaA, headquartered in Rockland, Massachusetts, with 1,000–5,000 employees and revenue between $500M–1B. The company develops therapies in neurology, endocrinology, oncology, and immunology, serving patients with multiple sclerosis, infertility, cancer, and myasthenia gravis. In 2026, the company received FDA approval for pimicotinib and acquired PostEra's fertility programs to expand its treatment portfolio.

Where is EMD Serono, Inc. headquartered?

EMD Serono, Inc. is headquartered in Rockland, Massachusetts (1 Technology Place, Rockland, Massachusetts, 02370).

How big is EMD Serono, Inc.?

EMD Serono, Inc. has an estimated 1,000-5,000 employees, with revenue in the $500M-1B range (estimated).

Related suppliers

Explore other suppliers in the LightSource directory:

Last verified Nov 2026. Is this your company? Request a correction.

Location & contact

Rockland, Massachusetts (HQ)Headquarters · United States
Rockland, Massachusetts (HQ)1 Technology Place, Rockland, Massachusetts, 02370, United StatesHeadquarters

Evaluating suppliers like these?

This profile is part of a public-data sample of the full LightSource directory. Book a demo to see the full LightSource marketplace and supplier discovery platform — 1M+ credible suppliers, with AI-run sourcing events.